Best in Biotech 13 Mar 2025
Nine biotechs thriving in Seattle in 2025
In this article, let us take a look at some of the major biotech companies in Seattle that are contributing to the biotech industry at large.
- Latest Posts
In Depth 12 Mar 2025
Checkpoint inhibitors in cancer: breakthroughs, setbacks, and what’s next
Checkpoint inhibitors are drugs that harness the immune system to destroy cancer cells. Let us review what’s been going on in the field.
In Depth 11 Mar 2025
The gender gap in clinical trials: Why women are still underrepresented
Find out what led biotech to a situation where women are underrepresented in clinical trials and how the industry is correcting it.
News and Trends 10 Mar 2025
23andMe: the collapse of a genomics giant
23andMe was once worth $6 billion and is now a penny stock. Layoffs, data breaches, and mass resignations plagued the genomics giant. How did it all unfold?
In Depth 7 Mar 2025
Catalonia: A biotech hub going from strength to strength, with Barcelona at its core
Take a deeper look at Catalonia’s biotech sector and overall life sciences hub, including the key drivers behind its success.
Podcast 7 Mar 2025
[Rebroadcast] How AI immune system mapping can boost drug discovery
Learn about the data gap in drug discovery and how machine learning (ML) can solve it in our talk with Noam Solomon, CEO and co-founder of Immunai.
ADVERTISEMENT
ADVERTISEMENT
News and Trends 6 Mar 2025
Top biotech deals of February 2025
Find out about the top biotech partnership deal of February 2025. Small molecules, T-cell engagers, and RNA medicines, were all part of major collaborations.
Best in Biotech 5 Mar 2025
Seven biotech companies keeping Taiwan dynamic in 2025
Discover 7 biotech companies in Taiwan, a rising regional player in precision medicine, immunotherapy, and drug development, backed by strong research and government support.
In Depth 4 Mar 2025
The biggest biotech funding rounds in February 2025
The companies Eikon Therapeutics, Sionna Therapeutics, and Abcuro bagged the biggest biotech funding rounds overall in February 2025.
R&D trends: Biotech assets & discovery platforms
Inpart’s latest report provides access to the most promising biotech assets and discovery platforms, shedding light on the latest trends in biotech R&D.
Best in Biotech 28 Feb 2025
Rare Disease Day: seven drugs awaiting approval in 2025
As we observe Rare Disease Day today, let us take a look at seven drugs poised to be approved to address rare diseases in 2025.
Podcast 28 Feb 2025
The TCR-T cell therapies of tomorrow
Sweden’s fastest growing private biotech, Anocca, is making plans for clinical trials in pancreatic cancer, with TCR-T cell therapy trials.
ADVERTISEMENT
